drugset / Trial / NCT01796795

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

NCT01796795 ↗

Phase 2 Suspended 102 enrolled G&E Herbal Biotechnology Co., LTD
RandomizedParallel-groupTriple-blindTreatment

Summary

This phase II study is to evaluate the efficacy of SR-T100 gel in complete clearance of target warts at different concentrations (1.0% and 2.3% of SM in Solanum undatum plant extract) in patients with CW.

Timeline

Start
2030-09
Primary completion
2033-04
Completion
2033-08

Outcome

Outcome not reported

Stopped: “Budget issue.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator SR-T100 Unknown 1 % Topical
Comparator SR-T100 Unknown 2.3 % Topical

Indications